Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
There is a choice for immunosuppressive drug nephrotoxicity: is it time to change
Journal of Nephrology, 07/02/09
Stallone G et al. - The central issue in organ transplantation remains suppression of allograft rejection. Thus, development of immunosuppressive drugs is the key to successful allograft function. To obtain significant long-term improvement in renal allograft outcomes, it may be necessary to adopt new immunosuppressive regimens that rely less on CNIs.
Related Articles
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors
European Journal of Cancer, 10/23/09
Relevance Score: 85%
What I tell my patients about contrast medium nephrotoxicity
British Journal of Renal Medicine, 10/27/09
Relevance Score: 82%
Long-Term Evaluation of Ifosfamide-Related Nephrotoxicity in Children
Journal of Clinical Oncology, 10/26/09
Relevance Score: 82%
Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells
American Journal of Physiology: Renal Physiology, 11/12/09
Relevance Score: 80%
Renal Dendritic Cells Ameliorate Nephrotoxic Acute Kidney Injury
Journal of the American Society of Nephrology, 11/04/09
Relevance Score: 80%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients
Nephrology Dialysis Transplantation, 12/08/09
Impact of anti-angiogenic treatments on metastatic renal cell carcinoma
Expert Review of Anticancer Therapy, 12/08/09
Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: An in vitro study
The International Journal of Artificial Organs, 12/07/09
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-Analyses Qualify Metzincins and Related Genes as Acute Rejection Markers in Renal Transplant Patients
American Journal of Transplantation, 12/08/09
Centers for Disease Control High-Risk Donors and Kidney Utilization
American Journal of Transplantation, 12/08/09
Measuring vs estimating glomerular filtration rate in kidney transplantation
Transplantation Reviews, 12/07/09
Article Search
Sponsor


See Latest Articles


